2-(Cyclonon-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Catalog No. :
ACZCTV429
CAS No. :
1041002-91-8
Molecular Formula :
C15H27BO2
Molecular Weight :
250.19

IUPAC Name:2-(cyclonon-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(Cyclonon-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$570.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Cyclonon-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
IUPAC Name2-(cyclonon-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
MDL No.MFCD16659016
Molecular FormulaC15H27BO2
Molecular Weight250.19
SMILESCC1(C)OB(OC1(C)C)C1=CCCCCCCC1
InChI KeyMBBBUKJYFHSXDR-UHFFFAOYSA-N
Synonym2-(1-Cyclononen-1-yl)-4,4,5,5-tetraMethyl-1,3,2-dioxaborolane;1,3,2-Dioxaborolane, 2-(1-cyclononen-1-yl)-4,4,5,5-tetraMethyl-;1-Cyclononen-1-yl-boronic acid pinacol ester;2-(Cyclonon-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
CAS No.1041002-91-8

Safety Data

Pictogram
Toxic
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZCTV429 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZCTV429 route product structure diagram
    ACZCTV4291041002-91-8
Inquiry

2. ACZCTV429 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACZCTV429 route product structure diagram
    ACZCTV4291041002-91-8
Inquiry

Comments (0)